Merck Expands Biosafety Testing Laboratory in Singapore to Strengthen Services Across Asia Pacific
AI Summary
Merck announced the expansion of its biosafety testing laboratory in Singapore, enhancing its molecular testing capabilities and supporting biopharma customers across the Asia Pacific region with faster, sensitive, and sustainable services.
Expansion adds first BioReliance® Cell Line Characterization and GMP Next-GenerationSequencingin Asia Pacific Enhanced testing capabilities to deliver speed, sensitivity, and sustainability for biopharma customers in the region Supports industry shift to molecular methods and animal-free testing SINGAPORE – Media OutReach Newswire – 11 August 2026 – Merck, a leading science and technology company, is expanding […]